Lung Cancer Trial, By Invitation NCT06549088 Sponsor: University of California, Irvine Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06549088
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older
  • People who have a lung nodule (a small spot on the lung) that has been found or is suspected on a scan or imaging test
  • People who are having surgery to remove part of their lung, whether through open surgery, keyhole (endoscopic), or robotic-assisted surgery
  • People whose doctor has already ordered a standard tissue examination (pathology test) of the removed lung tissue as part of their normal care
  • Adults who are having lung surgery to remove a lung mass

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under 18 years of age
  • People who are pregnant, or people who are currently incarcerated
  • People who do not have a standard pathology test ordered for their removed lung tissue as part of their normal care
  • People who have an urgent (RUSH) pathology order placed for their removed lung tissue (confirm with trial site)
  • People with any condition that the lead trial doctor believes could affect their safety or the quality of their care

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
University of California, Irvine
Registry
ClinicalTrials.gov
Start date
7 August 2023
Est. completion
1 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Markers of native lung parenchyma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov